Platelet-activating factor and liver metastasis of colorectal cancer - PubMed (original) (raw)

. 2005 Jan 20;113(3):503-5.

doi: 10.1002/ijc.20585.

• PMID: 15455343
• DOI: 10.1002/ijc.20585

Platelet-activating factor and liver metastasis of colorectal cancer

Yves Denizot et al. Int J Cancer. 2005.

No abstract available

PubMed Disclaimer

Similar articles

• Platelet-activating factor and human thyroid cancer.
  Denizot Y, Chianéa T, Labrousse F, Truffinet V, Delage M, Mathonnet M. Denizot Y, et al. Eur J Endocrinol. 2005 Jul;153(1):31-40. doi: 10.1530/eje.1.01947. Eur J Endocrinol. 2005. PMID: 15994743
• Is there a role of platelet-activating factor in human lung cancer?
  Denizot Y, Desplat V, Drouet M, Bertin F, Melloni B. Denizot Y, et al. Lung Cancer. 2001 Aug-Sep;33(2-3):195-202. doi: 10.1016/s0169-5002(01)00197-0. Lung Cancer. 2001. PMID: 11551414
• Platelet-activating factor and human meningiomas.
  Denizot Y, De Armas R, Caire F, Pommepuy I, Truffinet V, Labrousse F. Denizot Y, et al. Neuropathol Appl Neurobiol. 2006 Dec;32(6):674-8. doi: 10.1111/j.1365-2990.2006.00775.x. Neuropathol Appl Neurobiol. 2006. PMID: 17083481
• [Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system].
  Shebzukhov IuV, Mysiakin EB. Shebzukhov IuV, et al. Vopr Med Khim. 1996 Oct-Dec;42(4):278-83. Vopr Med Khim. 1996. PMID: 9254510 Review. Russian.
• Platelet-activating factor and related lipid mediators.
  Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Prescott SM, et al. Annu Rev Biochem. 2000;69:419-45. doi: 10.1146/annurev.biochem.69.1.419. Annu Rev Biochem. 2000. PMID: 10966465 Review.

Cited by

• Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
  Aponte M, Jiang W, Lakkis M, Li MJ, Edwards D, Albitar L, Vitonis A, Mok SC, Cramer DW, Ye B. Aponte M, et al. Cancer Res. 2008 Jul 15;68(14):5839-48. doi: 10.1158/0008-5472.CAN-07-5771. Cancer Res. 2008. PMID: 18632638 Free PMC article.
• VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
  Mathonnet M, Descottes B, Valleix D, Labrousse F, Denizot Y. Mathonnet M, et al. World J Gastroenterol. 2006 Feb 7;12(5):830-1. doi: 10.3748/wjg.v12.i5.830. World J Gastroenterol. 2006. PMID: 16521208 Free PMC article. No abstract available.
• ABC transporters in cancer: more than just drug efflux pumps.
  Fletcher JI, Haber M, Henderson MJ, Norris MD. Fletcher JI, et al. Nat Rev Cancer. 2010 Feb;10(2):147-56. doi: 10.1038/nrc2789. Epub 2010 Jan 15. Nat Rev Cancer. 2010. PMID: 20075923
• Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma.
  Mathonnet M, Descottes B, Valleix D, Truffinet V, Labrousse F, Denizot Y. Mathonnet M, et al. World J Gastroenterol. 2006 May 7;12(17):2773-8. doi: 10.3748/wjg.v12.i17.2773. World J Gastroenterol. 2006. PMID: 16718768 Free PMC article.
• Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells.
  Puebla-Osorio N, Damiani E, Bover L, Ullrich SE. Puebla-Osorio N, et al. Cell Death Dis. 2015 May 7;6(5):e1745. doi: 10.1038/cddis.2015.115. Cell Death Dis. 2015. PMID: 25950475 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Medical

  • MedlinePlus Health Information